White Goods & Wider Essentials - Crisis Resilience Fund

Description: Cheshire East Council is undertaking a soft market testing exercise to assess interest from organisations within Cheshire East in supplying white goods, wider essentials and related services across the borough. This questionnaire will be used to gather feedback from suppliers to inform the service and procurement design.

Summary: Cheshire East Borough Council is currently in the planning stage of a procurement process titled "White Goods & Wider Essentials - Crisis Resilience Fund," aimed at sourcing white goods, wider essentials, and related services. The process falls under the goods category, with a focus on furniture, furnishings, domestic appliances, and cleaning products. The council invites businesses within the Cheshire East area to participate in a preliminary market engagement, which requires interested parties to submit a completed questionnaire by 9 January 2026. The contract period is planned to start on 1 April 2026 and initially end on 31 March 2027, with potential extensions up to 2029. The procurement value is projected at £1,800,000, gross (£1,500,000 net).

CCDE System for Healthier Futures

Description: The Authority seeks to appoint a supply partner to provide a CCDE system to support its new hospital development programme. The new Hospital programme is known as Healthier Futures. The contract term is 6 years from 1 April 2026. Full details of the Authority's requirements are set out in the specification document

Summary: The MID CHESHIRE HOSPITALS NHS FOUNDATION TRUST is conducting a tender process to procure a CCDE system as part of its Healthier Futures hospital development programme. The procurement falls under the public authority central government category and is being held in Crewe, United Kingdom. The tender is specifically categorised under software packages and IT services, covering multiple UK regions. The process is currently in the tender stage, utilising a selective procurement method described as a competitive flexible procedure. Interested parties must submit a Pre-Qualification Questionnaire (PQQ) by 23 January 2026, with the contract slated to commence on 1 April 2026 and extend over six years.

Highways Framework

Description: Blackpool Council are establishing a lotted - Highways surfacing and civil engineering works Framework. The procurement will be conducted as an open tender and will establish a framework for a 4-year period. Call off contracts may be entered into from the framework in the manner described within the tender documents. The framework will consist of two lots as follows: Lot 1 - Highways Surfacing - Surfacing includes re-surfacing and re-construction of the highway network using conventional surfacing materials consisting of flexible and rigid pavement treatments (hot, warm and cold mix asphalts/concrete) Lot 2 - Highways Civils - Civil Engineering Works includes construction of improvement works on or associated with the highway network The intention is to establish a framework of up to 4 Suppliers for lot 1 and (read more...)

Summary: Blackpool Council is leading a procurement process to establish a Highways Framework, divided into two lots: Highways Surfacing and Highways Engineering Works. The procurement is conducted as an open tender and is at the tender stage. The tender, identified by the title "Highways Framework", focuses on works in the highways and civil engineering sector, primarily covering regions UKD3 and UKD4 in the United Kingdom. Relevant key dates include the tender period ending on 26th January 2026 and the potential contract awards by 27th February 2026. The framework agreement will span four years, starting from 1st April 2026, with a collective ceiling value of £200,000,000. In addition to Blackpool Council, this framework will also be available to various local authorities, including Lancashire County and multiple Greater Manchester councils.

PACE Interim Impact Report

Description: PACE (Pathways to Antimicrobial Clinical Efficacy) is a PS30 million initiative supporting and funding early-stage innovation in medicines and diagnostics, aimed at tackling AMR. It was established in September 2023 and is a collaboration between Innovate UK (IUK), LifeArc, and Medicines Discovery Catapult (MDC) - three leaders in the UK's health innovation and research community. PACE brings together the funding, resources, and partnerships to help innovators progress their early-stage antimicrobial drug and diagnostics projects with greater speed, support and confidence - giving the best AMR innovations the greatest chance of success. PACE will create a path to value through 3 strategic goals which will be underpinned by effective programme management and delivery: Grow a pipeline of high-quality antimicrobial drugs and associated diagnostics aligned with unmet needs and route (read more...)

Summary: The Medicines Discovery Catapult Limited, a sub-central government public authority located in Macclesfield, UK, is seeking an external provider to conduct an interim impact review for the PACE (Pathways to Antimicrobial Clinical Efficacy) programme. This procurement is aimed at producing an interim report evaluating the progress and impact of PACE activities, which underpin a £30 million initiative supporting early-stage innovation in the field of antimicrobial drugs and diagnostics. The tender, titled "PACE Interim Impact Report," is open for electronic submissions until 9 January 2026. It involves business and management consultancy services within the UK region, with a total contract value standing at £50,000. The tender process is open and below threshold, with quality being the predominant award criterion.

PACE Interim Impact Report

Description: PACE (Pathways to Antimicrobial Clinical Efficacy) is a PS30 million initiative supporting and funding early-stage innovation in medicines and diagnostics, aimed at tackling AMR. It was established in September 2023 and is a collaboration between Innovate UK (IUK), LifeArc, and Medicines Discovery Catapult (MDC) - three leaders in the UK's health innovation and research community. PACE brings together the funding, resources, and partnerships to help innovators progress their early-stage antimicrobial drug and diagnostics projects with greater speed, support and confidence - giving the best AMR innovations the greatest chance of success. PACE will create a path to value through 3 strategic goals which will be underpinned by effective programme management and delivery: Grow a pipeline of high-quality antimicrobial drugs and associated diagnostics aligned with unmet needs and route (read more...)

Summary: The Medicines Discovery Catapult Limited, a sub-central government public authority located in Macclesfield, UK, is seeking an external provider to conduct an interim impact review for the PACE (Pathways to Antimicrobial Clinical Efficacy) programme. This procurement is aimed at producing an interim report evaluating the progress and impact of PACE activities, which underpin a £30 million initiative supporting early-stage innovation in the field of antimicrobial drugs and diagnostics. The tender, titled "PACE Interim Impact Report," is open for electronic submissions until 9 January 2026. It involves business and management consultancy services within the UK region, with a total contract value standing at £50,000. The tender process is open and below threshold, with quality being the predominant award criterion.

Creative Design Agency

Description: This tender is for services relating to our communications and marketing function, including branding, design, marketing material production, photography and filming as part Of CCS Framework RM6124 Communications Marketplace DPS. We have conducted a filtered search of the framework suppliers and a Capability Assessment to reach an eventual shortlist of Suppliers. It is recommended any interested parties join the above DPS for future opportunities.

Summary: The Medicines Discovery Catapult Limited is currently undertaking a tender process titled "Creative Design Agency," focusing on miscellaneous business and related services. This procurement, falling under the CPV code 79900000, is active and pertains to services for communications and marketing, including branding and design work. The contract location is in the North West region of the United Kingdom, with a tender end date of 6th January 2026 and a contract period from 2nd February 2026 to 1st February 2030. This tender is part of the CCS Framework RM6124 Communications Marketplace DPS and utilises a selective procurement method via a dynamic purchasing system, offering an estimated value of £200,000. Interested parties are encouraged to join the DPS for forthcoming opportunities.

Scientific Consultant for Medicines Discovery Catapult

Description: Medicines Discovery Catapult (MDC) is an independent, not-for-profit innovation centre for drug discovery and part of the Catapult Network established by Innovate UK. MDC's vision is to reshape drug discovery for patient benefit by transforming great UK science into better treatments through partnership. It supports drug discovery innovators by making world-class expertise, facilities, complex technologies, and advanced analytics accessible to enable successful medicines discovery. MDC develops pioneering, impactful R&D collaborations across biotech, academia, technology companies, charities, and global pharma. It brings these communities together in active, focused national programmes that target high-risk areas of patient need. This requirement originates from the Partnership Team at Medicines Discovery Catapult (MDC), which includes national programmes across neuroscience and infection, virtual R&D, and complex medicine. The team plays a central role in (read more...)

Summary: The Medicines Discovery Catapult Limited seeks a Scientific Consultant to aid its efforts in drug discovery innovation, focusing on neuroscience and other high-risk patient needs. As the contracting authority, based in Macclesfield, UK, the organisation is looking to expand and delve into areas such as neurodegenerative diseases and CNS drug delivery. This procurement process, initiated under an open competition below the threshold, is currently at the tender stage, with submissions due by 19th December 2025. The contract, valued at £75,000, is scheduled to commence on 1st February 2026, lasting until 31st August 2026, with possible renewals. Industry classification centers around research and development consultancy services.

The PROVISION OF Holiday Activities and Food (HAF) Programme 2026-2029

Description: Cheshire East Council is seeking to commission a number of providers to deliver face to face school holiday activities for young people in Cheshire East. The holiday activities and food (HAF) programme is a 'Department for Education' (DfE) initiative enabling local authorities to coordinate a programme that provides school age young people between the ages of 4 - 16, and up to age 18 for eligible SEND young people, with healthy food and enriching activities during the summer and winter holidays. These school holiday activities provide young people with: * positive and safe things to do and places to go * the opportunity to spend time with friends, to develop personally and socially, and reduce isolation * the chance to undertake new activities and have new experiences Cheshire (read more...)

Summary: Cheshire East Council is inviting bids for the provision of the Holiday Activities and Food (HAF) Programme, set to run from April 2026 to March 2029, with procurement active under the open procedure method. This initiative, supported by the Department for Education, focuses on delivering engaging school holiday activities combined with nutritional support for young people aged 4-16, expanding to 18 for those with Special Educational Needs and Disabilities (SEND) within Cheshire East. The tender, divided into two lots—general HAF provision and specialist support including SEND and teenager-specific opportunities—falls under industry categories such as children's holiday-camp services and social work services without accommodation. Key dates include an enquiry period ending on 19th December 2025 and a tender submission deadline of 9th January 2026. The awarding phase is scheduled to conclude by 10th February 2026, with services commencing on 1st April 2026.

Senior Recruitment Services for Medicines Discovery Catapult

Description: Medicines Discovery Catapult (MDC) are establishing an Executive and Senior Search contract to meet MDC's requirements. MDC do not guarantee any volume or value of work from this Executive and Senior Search contract; however, it is MDC's intention to use the contract for the search and replacement of specific roles. However, the MDC reserve the right to procure services outside of the contract if it sees fit. The contract includes the search, headhunting and recruitment of roles within MDC to source senior or specialist staff. The typical scope of roles / vacancies will include, but are not limited to: Board roles CEO C suite Senior Leadership roles across all disciplines Niche / specific roles All of the above to include: Permanent staff; Fixed Term Staff; Temporary Staff; and (read more...)

Summary: The procurement process undertaken by Medicines Discovery Catapult Limited (MDC), a public authority functioning under sub-central government, focuses on Senior Recruitment Services. This open procedure targets the recruitment industry and is applicable throughout the United Kingdom. The process is currently in the tender stage, with the tender period concluding on 16 December 2025. Interested parties can submit their queries by 2 December 2025. The contract allows for recruiting roles such as board members, CEO, C suite, senior leadership across disciplines, and niche positions. The estimated value for the procurement is approximately £1,800,000 with potential for further interim staffing arrangements.

Senior Recruitment Services for Medicines Discovery Catapult

Description: Medicines Discovery Catapult (MDC) are establishing an Executive and Senior Search contract to meet MDC's requirements. MDC do not guarantee any volume or value of work from this Executive and Senior Search contract; however, it is MDC's intention to use the contract for the search and replacement of specific roles. However, the MDC reserve the right to procure services outside of the contract if it sees fit. The contract includes the search, headhunting and recruitment of roles within MDC to source senior or specialist staff. The typical scope of roles / vacancies will include, but are not limited to: Board roles CEO C suite Senior Leadership roles across all disciplines Niche / specific roles All of the above to include: Permanent staff; Fixed Term Staff; Temporary Staff; and (read more...)

Summary: The procurement process undertaken by Medicines Discovery Catapult Limited (MDC), a public authority functioning under sub-central government, focuses on Senior Recruitment Services. This open procedure targets the recruitment industry and is applicable throughout the United Kingdom. The process is currently in the tender stage, with the tender period concluding on 16 December 2025. Interested parties can submit their queries by 2 December 2025. The contract allows for recruiting roles such as board members, CEO, C suite, senior leadership across disciplines, and niche positions. The estimated value for the procurement is approximately £1,800,000 with potential for further interim staffing arrangements.